Fate Therapeutics Highlights FT522 Off-the-shelf, ADR-armed CAR NK Cell Product Candidate at 2024 ACR Convergence
Phase 1 Basket Study for B Cell-mediated Autoimmune Diseases to Assess FT522 as Add-on to Standard-of-care Induction and Maintenance Regimens ...
Is the Xero share price heading beyond $200?
Goldman Sachs thinks this high-flying stock can scale new heights. The post Is the Xero share price heading beyond $200?
monday.com Ltd. (MNDY): A Bull Case Theory
We came across a bullish thesis on monday.com Ltd. (MNDY) on Rijnberk InvestInsights’ Substack by Daan Rijnberk. In this article, we will summarize the bulls’ thesis on MNDY. monday.com Ltd. (MNDY)’s ...